Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Easywell Biomedicals, Inc. (1799) Financial Statements

Easywell Biomedicals, Inc. Financial Overview

Easywell Biomedicals, Inc.'s market cap is currently NT$6.24B. The company's EPS TTM is NT$-0.13; its P/E ratio is -264.14; and it has a dividend yield of 4.07%. Easywell Biomedicals, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 597.41MNT$ 540.44MNT$ 271.63MNT$ 178.90MNT$ 197.28M
Gross ProfitNT$ 245.71MNT$ 299.40MNT$ 170.72MNT$ 76.31MNT$ 50.43M
Operating IncomeNT$ -67.20MNT$ -69.81MNT$ -162.74MNT$ -151.03MNT$ -153.58M
EBITDANT$ 23.93MNT$ 12.75MNT$ -85.50MNT$ -84.48MNT$ -82.70M
Net IncomeNT$ -73.14MNT$ -97.47MNT$ -144.82MNT$ -161.00MNT$ -150.39M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 451.69MNT$ 466.10MNT$ 348.03MNT$ 339.54MNT$ 439.28M
Total AssetsNT$ 1.29BNT$ 1.51BNT$ 1.21BNT$ 1.17BNT$ 1.26B
Total DebtNT$ 425.91MNT$ 564.28MNT$ 386.34MNT$ 349.96MNT$ 325.50M
Net DebtNT$ 144.85MNT$ 238.62MNT$ 123.44MNT$ 190.93MNT$ 172.47M
Total LiabilitiesNT$ 589.74MNT$ 766.17MNT$ 589.99MNT$ 402.60MNT$ 351.82M
Stockholders' EquityNT$ 690.67MNT$ 718.61MNT$ 612.81MNT$ 738.46MNT$ 873.66M
Cash Flow
Free Cash FlowNT$ 109.37MNT$ -171.79MNT$ -170.00MNT$ -60.99MNT$ -136.02M
Operating Cash FlowNT$ 124.78MNT$ -159.04MNT$ -151.45MNT$ -53.50MNT$ -128.31M
Investing Cash FlowNT$ -25.04MNT$ -47.66MNT$ 87.46MNT$ 72.66MNT$ -182.54M
Financing Cash FlowNT$ -142.70MNT$ 263.06MNT$ 177.84MNT$ -10.55MNT$ 320.31M

Currency in TWD

Easywell Biomedicals, Inc. Earnings and Revenue History

-400M0400M800M-120 %-80 %-40 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Easywell Biomedicals, Inc. Liabilities to Assets

0600M1.2B1.8B24 %36 %48 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Easywell Biomedicals, Inc. Cash Flow

-300M-200M-100M0100M200M300M400M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Easywell Biomedicals, Inc. Forecast EPS vs Actual EPS

-0.5-0.4-0.3-0.2-0.100.10.2Q2 25Q3 25Q4 25Q2 26Q3 26EPS EstimateBeatMiss
Earnings >